Early chronic kidney disease (CKD stage 3a): how to tell people they have the condition British Journal of Primary Care Nursing. Cardiovascular Disease, Diabetes & Kidney CareThomas, Nicola
Kidney InternationalKirsztajn GM, Suassuna JHR, Bastos MG (2009) Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B. Kidney Int 76:462-463 (author reply 463-464)Kirsztajn GM, Suassuna JH, Bastos MG. Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B . Kid Int ...
Response to 'Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B' 来自 学术范 喜欢 0 阅读量: 15 作者:CG Winearls,RJ Glassock 摘要: Kidney International aims to inform the renal researcher and practicing nephrologists on all aspects of renal research. Clinical and basic renal ...
Over the past five years there have been dramatic changes to the way in which people with chronic kidney disease (CKD) are being managed in primary care. As a result of policy changes there are now many more people with CKD being identified, especially those with stage 3A. This article dea...
Among older adults with chronic kidney disease (CKD), the comparative event rates of end-stage renal disease (ESRD) and cause-specific death are unknown. T
subclinical organ damage, which determines cardiovascular prognosis. The aim of our study was to evaluate the prevalence of left ventricular hypertrophy (LVH), LV geometry patterns, and LV systolic/diastolic dysfunction among men with uncontrolled AH and chronic kidney disease (CKD) stages 3A and 3B...
opens in a new tab or windowThe novel SGLT-2 inhibitor bexagliflozin effectively lowered HbA1c levels in people with advanced chronic kidney disease (CKD), according to a phase III clinical trial. The analysis included 300 individuals with type 2 diabetes, including those with stages 3a and 3b...
BackgroundLate-stage chronic kidney disease (LS-CKD) can be defined by glomerular filtration rate (GFR) 0–30?mL/min. It is a period of risk for medication discrepancies because of frequent hospitalizations, fragmented medical care, inadequate communication and polypharmacy. In this study, we soug...
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes Background: Rare variants in gene coding regions likely have a greater impact on disease-related phenotypes than common variants through disrupti...
Plasma content of copeptin increases with the advancement of chronic kidney disease (CKD). The purpose of this study was to evaluate copeptin content as a potential marker of CKD, as a single pathology or with coexisting heart failure. Seventy-six patients were divided into the following groups:...